4Filing Date: Aug 21, 2026

Intuitive (ISRG)

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0002010300-26-000029
Total Value$59.4K
Trades2
Insiders1

Transaction Details

Brosius Mark
EVP & Chief Mfg and Supply Cha·Direct
Sell · Dispose
Common Stock
Shares-77
Price$375.57
Total Value$28.9K
Shares Owned After881
Transaction DateAug 21, 2026
10b5-1
Footnotes ▸

The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027.

Brosius Mark
EVP & Chief Mfg and Supply Cha·Direct
Sell · Dispose
Common Stock
Shares-77
Price$396.37
Total Value$30.5K
Shares Owned After958
Transaction DateAug 20, 2026
10b5-1
Footnotes ▸

The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027.

Post-Transaction Holdings

Brosius Mark · EVP & Chief Mfg and Supply Cha
SecuritySharesChange
Common Stock881-154 (-14.88%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-08-20 10b5-1 Pre-arranged Plan: Yes --- Issuer --- Name: INTUITIVE SURGICAL INC (ISRG) CIK: 0001035267 --- Reporting Owner --- Name: Brosius Mark CIK: 0002010300 Role: Officer (EVP & Chief Mfg and Supply Cha) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-08-20 | Code: S (Open market sale) Shares: -77 | Price: $396.37 Total Value: $30,520.49 Shares Owned After: 958 | Ownership: D (Direct) Footnotes: [F1] The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027. [Transaction #2] Security: Common Stock Date: 2026-08-21 | Code: S (Open market sale) Shares: -77 | Price: $375.57 Total Value: $28,918.89 Shares Owned After: 881 | Ownership: D (Direct) Footnotes: [F1] The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027. --- Footnotes (Complete Index) --- F1: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 14, 2027. --- Signature --- /s/ By: Stephanie Lim-Ignacio For: Brosius, Mark (2026-08-21)

keid analysis is for reference only and does not constitute investment advice.